Aimmune Therapeutics
Aimmune Therapeutics is a clinical-stage biopharmaceutical company founded to address the unmet medical need in food allergy, which currently has no approved treatments. Our mission is to improve the lives of people with food allergies, based on our proprietary desensitization treatments in development. Aimmune’s lead investigational drug for peanut allergy, AR101, is in Phase 3 clinical testing in North America and Europe. Headquartered in the heart of San Francisco’s biotechnology hub, Brisbane, California, Aimmune has additional offices in the Kings Cross area of London, and in Raleigh, North Carolina.
aimmune.comBrisbane, CA, USA, 8000 Marina Blvd, Brisbane, CA, USA, California, USA
Founded in 2011
Inaccurate data? Flag it here.Open jobs at Aimmune Therapeutics
We only use strictly necessary, first-party cookies on this job board. These are cookies that are necessary to deliver this service to you, or are necessary for Foresite Capital LP to understand how it is being used. Read our Cookie Policy.